Robert C. Bast

Affiliations: 
Department of Experimental Therapeutics University of Texas M.D. Anderson Cancer Center 
Google:
"Robert Bast"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Artibani M, Masuda K, Hu Z, et al. (2021) Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor initiating cells. Jci Insight
Fahrmann JF, Irajizad E, Kobayashi M, et al. (2021) A MYC-Driven Plasma Polyamine Signature for Early Detection of Ovarian Cancer. Cancers. 13
Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, et al. (2021) Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy. 1-382
Fan D, Yang H, Mao W, et al. (2021) A Novel Salt Inducible Kinase 2 Inhibitor, ARN-3261, Sensitizes Ovarian Cancer Cell Lines and Xenografts to Carboplatin. Cancers. 13
Bast RC, Lu Z, Han CY, et al. (2020) Biomarkers and Strategies for Early Detection of Ovarian Cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology
Yang H, Mao W, Rodriguez-Aguayo C, et al. (2020) Correction: Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 26: 5050
Blessing AM, Santiago-O'Farrill JM, Mao W, et al. (2020) Elimination of dormant, autophagic ovarian cancer cells and xenografts through enhanced sensitivity to anaplastic lymphoma kinase inhibition. Cancer
Kobayashi M, Katayama H, Irajizad E, et al. (2020) Proteome Profiling Uncovers an Autoimmune Response Signature That Reflects Ovarian Cancer Pathogenesis. Cancers. 12
Sutton MN, Lu Z, Li YC, et al. (2019) DIRAS3 (ARHI) Blocks RAS/MAPK Signaling by Binding Directly to RAS and Disrupting RAS Clusters. Cell Reports. 29: 3448-3459.e6
Yang WL, Lu Z, Guo J, et al. (2019) Human epididymis protein 4 antigen-autoantibody complexes complement cancer antigen 125 for detecting early-stage ovarian cancer. Cancer
See more...